Recherche
-
Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors
(Cancer Immunology, Immunotherapy. vol. 71, n° 11, pp. 2609-2618, 2022-11)Article de revue -
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study
(European Journal of Clinical Pharmacology. vol. 78, n° 12, pp. 1981-1990, 2022-10-26)Article de revue -
Alopecia areata: Recent advances and emerging therapies
(Annales de Dermatologie et de Venereologie. vol. 149, pp. 222-227, 2022-06-23)Article de revue -
Characterization of the novel HLA-C*07:01:101 allele by sequencing-based typing
(HLA: Immune Response Genetics. vol. 98, n° 6, pp. 556-557, 2021)Article de revue -
Efficacy of plasmapheresis and semi-selective immunoadsorption for removal of anti-HLA antibodies
(Journal of Clinical Apheresis. vol. 36, n° 3, pp. 291-298, 2021-06)Article de revue -
Characterization of the novel HLA-DQB1*06:371 allele by sequencing-based typing
(HLA: Immune Response Genetics. vol. 97, n° 2, pp. 175-176, 2021-02)Article de revue -
Characterization of the novel HLA-A*11:376 allele by sequencing-based typing
(HLA: Immune Response Genetics. vol. 97, n° 5, pp. 447-448, 2021-05)Article de revue -
Characterization of the novel HLA-DQB1*06:374 allele by sequencing-based typing
(HLA: Immune Response Genetics. vol. 97, n° 4, pp. 382-383, 2021-04)Article de revue -
Characterization of the novel HLA-C*06:314 allele by sequencing-based typing
(HLA: Immune Response Genetics. vol. 98, n° 1, pp. 70-71, 2021-04-27)Article de revue -
Characterization of the novel HLA-DPB1*1151:01 allele by sequencing-based typing
(HLA: Immune Response Genetics. vol. 97, n° 5, pp. 470-471, 2021-05)Article de revue